The ectoparasite, Pthirus pubis (PtP), (crab or pubic louse) has plagued primates from pre-historic apes to Homo sapiens. We combed the literature from antiquity to present day using Medline and …
Intradermal testing for autoimmune progesterone dermatitis: should we be basing our diagnosis on it?
Autoimmune progesterone dermatitis (APD) is a rare skin disorder with varying presentations, resulting from hypersensitivity to endogenous progesterone during the luteal phase of the menstrual cycle. The diagnosis has been …
Is apremilast for psoriasis as effective and safe as reported in clinical trials? Five-year experience from a Greek tertiary hospital.
Apremilast was approved as an effective and safe treatment for psoriasis, but clinical trial results may differ from real-life data. This retrospective cross-sectional study evaluated the long-term efficacy and safety …
Laryngeal mucous membrane pemphigoid serves as a prognostic factor for poor response to treatment with rituximab.
Mucous Membrane Pemphigoid (MMP) comprises a group of auto-antibody mediated subepidermal bullous diseases characterized by predominant involvement of mucous membranes and a tendency to scarring. Rituximab (RTX) has emerged as a …
Potential Predictive Biomarkers of Adalimumab Response in Patients with Hidradenitis Suppurativa.
Adalimumab provides significant efficacy for patients with hidradenitis suppurativa (HS) as demonstrated by at least 50% of patients achieving HS clinical response by week 12 that is maintained through week …
Screening May Improve Early Detection for Melanoma-Prone
Reduced thickness of melanoma lesions seen for patients receiving routine skin cancer screening, education about self-exam
Mobile Robotic System Perceived as Acceptable for Health Tasks
Survey suggests robotic system perceived as useful; patients report satisfaction with triage interview using mobile robotic system
Delayed immune-related adverse events with anti-PD1-based immunotherapy in melanoma.
IrAEs typically occur within 4 months of starting anti-PD1-based therapy (anti-PD1 +/- anti-CTLA4), but delayed irAEs (onset >12 months after commencement) can also occur. This study describes the incidence, nature …